Literature DB >> 17342757

Spinal cord dopamine receptor expression and function in mice with 6-OHDA lesion of the A11 nucleus and dietary iron deprivation.

Hongru Zhao1, Wen Zhu, Tianhong Pan, Wenjie Xie, Aijun Zhang, William G Ondo, Weidong Le.   

Abstract

It is suggested that dysfunction of the diencephalospinal dopaminergic (DAergic) pathway may cause restless legs syndrome. We examined the mRNA and protein levels as well as DA receptor subtypes function within the lumbar spinal cord of an RLS animal model. C57BL/6 male mice with or without iron deprivation were lesioned with 6-hydroxydopamine (6-OHDA) in the bilateral A11 nuclei. Locomotor behaviors were observed. DA concentration, mRNA, and protein levels of D1, D2, and D3 receptors in the lumbar spinal cords were analyzed, and the specific binding of D1, D2, and D3 receptors was determined using [(3)H]SCH23390, [(3)H]Spiperone, and [(3)H]PD128907 radioligands respectively. The behavioral tests showed that the locomotor activities were increased significantly in the mice treated with iron-deficiency (ID) diet and 6-OHDA lesions, which were reversed by the D2/D3 agonist ropinirole. DA in the spinal cord was decreased significantly by 6-OHDA lesioning in A11. D2/D3 mRNA and protein levels as well as their binding capacity in the spinal cord were decreased significantly by 6-OHDA lesions. ID with 6-OHDA lesions produced a synergistic greater decrease of D2 binding. Although ID increased D1 mRNA and protein expression in the spinal cord, it did not significantly change D1 receptor binding. The present study suggests that ID and 6-OHDA lesions in A11 nuclei differentially altered the D1, D2, and D3 receptors expression and binding capacity in the lumbar spinal cord of RLS animal model, which was accompanied by changes in locomotor activities. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17342757     DOI: 10.1002/jnr.21207

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  24 in total

Review 1.  Restless legs syndrome: pathophysiology, clinical presentation and management.

Authors:  Claudia Trenkwalder; Walter Paulus
Journal:  Nat Rev Neurol       Date:  2010-06       Impact factor: 42.937

2.  Expression and distribution of all dopamine receptor subtypes (D(1)-D(5)) in the mouse lumbar spinal cord: a real-time polymerase chain reaction and non-autoradiographic in situ hybridization study.

Authors:  H Zhu; S Clemens; M Sawchuk; S Hochman
Journal:  Neuroscience       Date:  2007-09-12       Impact factor: 3.590

Review 3.  Therapies for Restless Legs in Parkinson's Disease.

Authors:  Valérie Cochen De Cock
Journal:  Curr Treat Options Neurol       Date:  2019-11-09       Impact factor: 3.598

4.  Restless legs syndrome: pathophysiology and treatment.

Authors:  William G Ondo
Journal:  Curr Treat Options Neurol       Date:  2014-11       Impact factor: 3.598

5.  A Critical Role for Dopamine D5 Receptors in Pain Chronicity in Male Mice.

Authors:  Salim Megat; Stephanie Shiers; Jamie K Moy; Paulino Barragan-Iglesias; Grishma Pradhan; Rebecca P Seal; Gregory Dussor; Theodore J Price
Journal:  J Neurosci       Date:  2017-11-22       Impact factor: 6.167

6.  BTBD9 and dopaminergic dysfunction in the pathogenesis of restless legs syndrome.

Authors:  Shangru Lyu; Atbin Doroodchi; Hong Xing; Yi Sheng; Mark P DeAndrade; Youfeng Yang; Tracy L Johnson; Stefan Clemens; Fumiaki Yokoi; Michael A Miller; Rui Xiao; Yuqing Li
Journal:  Brain Struct Funct       Date:  2020-05-28       Impact factor: 3.270

7.  Presynaptic Inhibition of Primary Nociceptive Signals to Dorsal Horn Lamina I Neurons by Dopamine.

Authors:  Yong Lu; Maksym Doroshenko; Justas Lauzadis; Martha P Kanjiya; Mario J Rebecchi; Martin Kaczocha; Michelino Puopolo
Journal:  J Neurosci       Date:  2018-08-24       Impact factor: 6.167

8.  Neuroanatomical study of the A11 diencephalospinal pathway in the non-human primate.

Authors:  Quentin Barraud; Ibrahim Obeid; Incarnation Aubert; Gregory Barrière; Hugues Contamin; Steve McGuire; Paula Ravenscroft; Gregory Porras; François Tison; Erwan Bezard; Imad Ghorayeb
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240

9.  Deficiency of Meis1, a transcriptional regulator, in mice and worms: Neurochemical and behavioral characterizations with implications in the restless legs syndrome.

Authors:  Shangru Lyu; Hong Xing; Yuning Liu; Pallavi Girdhar; Keer Zhang; Fumiaki Yokoi; Rui Xiao; Yuqing Li
Journal:  J Neurochem       Date:  2020-09-23       Impact factor: 5.372

10.  Unaltered D1, D2, D4, and D5 dopamine receptor mRNA expression and distribution in the spinal cord of the D3 receptor knockout mouse.

Authors:  Hong Zhu; Stefan Clemens; Michael Sawchuk; Shawn Hochman
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2008-09-17       Impact factor: 1.836

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.